Meeder Asset Management Inc. Has $6.42 Million Stake in Encompass Health Co. (NYSE:EHC)

Meeder Asset Management Inc. boosted its position in Encompass Health Co. (NYSE:EHC - Free Report) by 43.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 66,405 shares of the company's stock after acquiring an additional 20,242 shares during the period. Meeder Asset Management Inc. owned 0.07% of Encompass Health worth $6,417,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Pathstone Holdings LLC lifted its position in Encompass Health by 54.5% during the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company's stock valued at $2,032,000 after purchasing an additional 7,412 shares during the period. Thrivent Financial for Lutherans lifted its holdings in Encompass Health by 26.0% in the third quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company's stock valued at $73,494,000 after buying an additional 156,938 shares during the period. Natixis Advisors LLC boosted its stake in Encompass Health by 7.8% in the third quarter. Natixis Advisors LLC now owns 101,296 shares of the company's stock valued at $9,789,000 after acquiring an additional 7,294 shares during the last quarter. CIBC Asset Management Inc grew its holdings in Encompass Health by 3.5% during the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company's stock worth $286,000 after acquiring an additional 100 shares during the period. Finally, OneDigital Investment Advisors LLC acquired a new position in shares of Encompass Health in the 3rd quarter valued at $207,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on EHC. Royal Bank of Canada lifted their price objective on Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 30th. Truist Financial reissued a "buy" rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Stephens reissued an "overweight" rating and set a $105.00 target price on shares of Encompass Health in a research note on Tuesday, August 6th. UBS Group lifted their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a research note on Wednesday, September 25th. Finally, Barclays increased their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $107.11.

Encompass Health Stock Down 0.2 %

NYSE:EHC traded down $0.15 on Tuesday, hitting $99.08. 520,623 shares of the company's stock were exchanged, compared to its average volume of 641,210. The company has a market cap of $9.98 billion, a P/E ratio of 23.93, a price-to-earnings-growth ratio of 1.31 and a beta of 0.88. The firm has a 50-day moving average price of $96.69 and a 200-day moving average price of $90.58. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. Encompass Health Co. has a 52 week low of $63.78 and a 52 week high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business's quarterly revenue was up 11.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.86 earnings per share. As a group, analysts expect that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health declared that its Board of Directors has approved a stock buyback program on Wednesday, July 24th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to repurchase up to 5.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its stock is undervalued.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date is Thursday, January 2nd. Encompass Health's dividend payout ratio (DPR) is presently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.